^
Association details:
| Biomarker: | LZTS1 overexpression |
|---|---|
| Cancer: | Breast Cancer |
| Drug: | paclitaxel (Tubulin inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Increased LZTS1 expression is associated with a good response to paclitaxel-based chemotherapy in breast cancer
Published date:
04/26/2022
Excerpt:
Overexpression of LZTS1 could sensitize human breast carcinoma xenografts to paclitaxel. In addition, tumor with high LZTS1 expression was more sensitive to chemotherapy with paclitaxel in breast cancer….
DOI:
https://doi.org/10.1016/j.prp.2022.153915